The Company focuses on evolving, manufacturing, and commercialization of therapeutics for cancer patients. Oncology Pharma offers antinuclear antibody that targets areas of necrosis present in solid tumors. Pharma assets in development are linked to cancer. Oncology Pharma offers antinuclear antibody that targets areas of necrosis present in solid tumors. In 2019, the global market for cancer drugs was respected at around 112.73 billion U.S. dollars, according to market research corporation Next MSC. By 2030, this market is forecasted to spread a value of 215 billion U.S. dollars.
Related Tags: International Conference on Molecular Oncology, World Congress on Advances in Oncology, International AIDS Conference, Precision oncology conference 2022, Cancer conference 2022, Cancer Pharma Conference 2022, Cancer Pharma Conference 2023, Cancer Pharma Congress 2022, Caner Pharma Congress 2023, European Congress on Cancer Pharma 2022.
Related Associations: American Cancer Society - Guideline Central, RSNA Radiological Society of North America, Singapore Cancer Society, Association of First Primary Cancer, Leading Cancer Charities and Organizations